Sign inJoin waitlistJoin the waitlist

Elizabeth Carey

Professor of Medicine · Mayo Clinic College of Medicine and Science

Credentials: · · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Transplant Hepatology
Mayo Clinic
2004–2005
2001–2004
Mayo Clinic College of Medicine and Science
1998–2001
Mayo Clinic College of Medicine and Science
1994–1998
University of Minnesota
1990–1994

Research

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Hepatology · 2021 · Last of 7 authors · 610 citations
Primary biliary cirrhosis
Review · The Lancet · 2015 · First of 3 authors · 422 citations
A multicenter study to define sarcopenia in patients with end-stage liver disease
Liver Transplantation · 2017 · First of 8 authors · 413 citations

KL
Keith Lindor
24 papers
David Douglas
19 papers
Hugo Vargas
19 papers
JR
Jorge Rakela
16 papers
Thomas Byrne
16 papers · 1 as a fellow
Ahmad Ali
13 papers · 1 as a fellow
Bashar Aqel
13 papers
Jennifer Lai
10 papers · 6 as a fellow
David Mulligan
8 papers
Cynthia Levy
7 papers
James Tabibian
7 papers · 2 as a fellow
Vijayan Balan
7 papers

Grants

A Prospective, Randomized, Multi-Centered, Placebo-Controlled Clinical Trial of Oral Vancomycin in Adults with Primary Sclerosing Cholangitis
Food and Drug Administration · R01
Contact PI · $1M · Mayo Clinic Arizona
2018–2025
Investigation of the Activity of Vidofludimus Calcium, a Novel, Orally Available, Small Molecule Inhibitor of Dihydroorotate Dehydrogenase, as a Treatment for Primary Sclerosing Cholangitis (PSC)
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $129.9K · Mayo Clinic Arizona
2020–2022

Clinical trials

Vancomycin for Primary Sclerosing Cholangitis
Principal investigator · Terminated · Phase 2, Phase 3
Elizabeth Carey
2020–2025
Vidofludimus Calcium for Primary Sclerosing Cholangitis
Principal investigator · Completed · Phase 2
Elizabeth Carey
2019–2020
LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Principal investigator · Terminated · Phase 2
Veloxis Pharmaceuticals
2007–2009